A Phase II Pilot Study of yttriuM-90 in Combination With capEcitabine and aTezolizumab for oligomEtastatic cOlorectal Cancer With unResectable lIver MeTastasEs (METEORITE)
OPEN TO ACCRUAL
II
NCT06555133
araufi2@BrownHealth.org
